Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 745

1.

Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells.

Dje N'Guessan P, Riediger F, Vardarova K, Scharf S, Eitel J, Opitz B, Slevogt H, Weichert W, Hocke AC, Schmeck B, Suttorp N, Hippenstiel S.

Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):380-6. doi: 10.1161/ATVBAHA.108.178319. Epub 2009 Jan 2.

2.

Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.

Lin YC, Lin JH, Chou CW, Chang YF, Yeh SH, Chen CC.

Cancer Res. 2008 Apr 1;68(7):2375-83. doi: 10.1158/0008-5472.CAN-07-5807.

3.

Histone acetylation and flagellin are essential for Legionella pneumophila-induced cytokine expression.

Schmeck B, Lorenz J, N'guessan PD, Opitz B, van Laak V, Zahlten J, Slevogt H, Witzenrath M, Flieger A, Suttorp N, Hippenstiel S.

J Immunol. 2008 Jul 15;181(2):940-7.

4.

Intracellular bacteria differentially regulated endothelial cytokine release by MAPK-dependent histone modification.

Schmeck B, Beermann W, van Laak V, Zahlten J, Opitz B, Witzenrath M, Hocke AC, Chakraborty T, Kracht M, Rosseau S, Suttorp N, Hippenstiel S.

J Immunol. 2005 Sep 1;175(5):2843-50.

5.

Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.

Lee WJ, Ou HC, Hsu WC, Chou MM, Tseng JJ, Hsu SL, Tsai KL, Sheu WH.

J Vasc Surg. 2010 Nov;52(5):1290-300. doi: 10.1016/j.jvs.2010.04.085. Epub 2010 Aug 8.

6.

Simvastatin reduces Chlamydophila pneumoniae-mediated histone modifications and gene expression in cultured human endothelial cells.

Schmeck B, Beermann W, N'Guessan PD, Hocke AC, Opitz B, Eitel J, Dinh QT, Witzenrath M, Krüll M, Suttorp N, Hippenstiel S.

Circ Res. 2008 Apr 25;102(8):888-95. doi: 10.1161/CIRCRESAHA.107.161307. Epub 2008 Feb 28.

7.
8.
9.

LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells.

Mattaliano MD, Huard C, Cao W, Hill AA, Zhong W, Martinez RV, Harnish DC, Paulsen JE, Shih HH.

Am J Physiol Cell Physiol. 2009 Jun;296(6):C1329-37. doi: 10.1152/ajpcell.00513.2008. Epub 2009 Mar 11.

10.

Oxidized-LDL through LOX-1 increases the expression of angiotensin converting enzyme in human coronary artery endothelial cells.

Li D, Singh RM, Liu L, Chen H, Singh BM, Kazzaz N, Mehta JL.

Cardiovasc Res. 2003 Jan;57(1):238-43.

PMID:
12504834
11.

Requirement of histone deacetylase activity for signaling by STAT1.

Klampfer L, Huang J, Swaby LA, Augenlicht L.

J Biol Chem. 2004 Jul 16;279(29):30358-68. Epub 2004 May 3.

12.

Inhibition of LOX-1 by statins may relate to upregulation of eNOS.

Mehta JL, Li DY, Chen HJ, Joseph J, Romeo F.

Biochem Biophys Res Commun. 2001 Dec 14;289(4):857-61.

PMID:
11735125
13.

Regulation of chemokine gene expression by hypoxia via cooperative activation of NF-kappaB and histone deacetylase.

Safronova O, Pluemsampant S, Nakahama K, Morita I.

Int J Biochem Cell Biol. 2009 Nov;41(11):2270-80. doi: 10.1016/j.biocel.2009.05.003. Epub 2009 May 13.

PMID:
19446037
14.

HMG-CoA reductase inhibitors reduce nicotine-induced expression of cellular adhesion molecules in cultured human coronary endothelial cells.

Cirillo P, Pacileo M, De Rosa S, Calabrò P, Gargiulo A, Angri V, Prevete N, Fiorentino I, Ucci G, Sasso L, Petrillo G, Musto D'Amore S, Chiariello M.

J Vasc Res. 2007;44(6):460-70. Epub 2007 Jul 26.

PMID:
17657162
15.

Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.

Rodríguez C, Alcudia JF, Martínez-González J, Guadall A, Raposo B, Sánchez-Gómez S, Badimon L.

Cardiovasc Res. 2009 Aug 1;83(3):595-603. doi: 10.1093/cvr/cvp136. Epub 2009 Apr 30.

PMID:
19406911
17.

CRP is a novel ligand for the oxidized LDL receptor LOX-1.

Shih HH, Zhang S, Cao W, Hahn A, Wang J, Paulsen JE, Harnish DC.

Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1643-50. doi: 10.1152/ajpheart.00938.2008. Epub 2009 Feb 27.

18.

Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.

Schönbeck U, Gerdes N, Varo N, Reynolds RS, Horton DB, Bavendiek U, Robbie L, Ganz P, Kinlay S, Libby P.

Circulation. 2002 Dec 3;106(23):2888-93.

20.

Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.

Mulhaupt F, Matter CM, Kwak BR, Pelli G, Veillard NR, Burger F, Graber P, Lüscher TF, Mach F.

Cardiovasc Res. 2003 Sep 1;59(3):755-66.

PMID:
14499877

Supplemental Content

Support Center